← Back to Investors

Polaris Partners

Venture capital firm active in healthcare and biotechnology sectors, with offices in Boston, New York, and San Francisco.

Location
US
Portfolio Companies
33
Focus
biotech-focused

Investment Thesis

Polaris Partners is a venture capital firm active in healthcare and biotechnology sectors, investing in transformative companies across life sciences.

Notes

  • Healthcare and biotechnology focus
  • Multi-office presence (Boston, New York, San Francisco)
  • Life sciences specialization

Partners & Team

  • Amy Schulman - Managing Partner
  • Brian Chee - Managing Partner
  • Terry McGuire - Founding Partner
  • Jon Flint - Founding Partner
  • Steve Arnold - Founding Partner

Focus Areas

  • Tech Bio
  • Deep Tech
  • Health
  • Healthcare
  • Biotechnology
  • Life Sciences

Portfolio Companies (Healthcare/Biotech)

  • Alnylam Pharmaceuticals (RNAi therapeutics)
  • Agios Pharmaceuticals (cancer metabolism)
  • 908 Devices (analytical devices)
  • AgBiome (agricultural biotechnology)

Additional Research Findings

  • Healthcare and biotechnology focus
  • Life sciences specialization
  • Strong portfolio track record

Portfolio Companies

NameLocationFoundedCategories
Alnylam PharmaceuticalsCambridge, Massachusetts, USA2002
biotechrna-therapeutics+3
Agios Pharmaceuticals--
biotechtherapeutics+1
908 DevicesBoston, Massachusetts, USA2012
analytical-deviceslife-sciences+2
AgBiome--
agricultural-biotechnologybiotech+1
FreenomeSouth San Francisco, California, USA2014
genomicscancer-detection+3
PathAIBoston, Massachusetts, USA2016
aipathology+3
Scholar RockCambridge, Massachusetts, USA2012
biotechtherapeutics+3
Selecta BiosciencesWatertown, Massachusetts, USA2007
biotechimmunotherapy+3
SQZ BiotechnologiesWatertown, Massachusetts, USA2013
biotechcell-therapy+3
Tectonic TherapeuticCambridge, Massachusetts, USA2019
biotechtherapeutics+3
TrevenaChesterbrook, Pennsylvania, USA2007
biotechpharmaceuticals+3
Triveni BioCambridge, Massachusetts, USA2021
biotechtherapeutics+2
TurbineBudapest, Hungary2015
aidrug-discovery+3
Vico TherapeuticsLeiden, Netherlands2017
biotechgene-therapy+3
X4 PharmaceuticalsBoston, Massachusetts, USA2015
biotechoncology+3
Engine BiosciencesSingapore & Cambridge, Massachusetts, USA2016
aidrug-discovery+3
Fate TherapeuticsSan Diego, California, USA2007
biotechcell-therapy+4
Glympse BioCambridge, Massachusetts, USA2015
diagnosticsbiomarkers+3
Genocea BiosciencesCambridge, Massachusetts, USA2006
biotechimmunotherapy+3
Ironwood PharmaceuticalsBoston, Massachusetts, USA1998
pharmaceuticalsgastrointestinal+2
KallyopeNew York, New York, USA2015
biotechgut-brain-axis+3
Kronos BioSan Mateo, California, USA2017
biotechprecision-medicine+3
KSQ TherapeuticsCambridge, Massachusetts, USA2015
biotechoncology+3
Lyndra TherapeuticsWatertown, Massachusetts, USA2015
drug-deliverypharmaceuticals+3
Momenta PharmaceuticalsCambridge, Massachusetts, USA2001
biotechbiosimilars+4
Neogene TherapeuticsLos Angeles, California, USA & Amsterdam, Netherlands2019
biotechcell-therapy+3
Neumora TherapeuticsWatertown, Massachusetts, USA2019
biotechneuroscience+2
Noema PharmaBasel, Switzerland2018
biotechneuroscience+2
Pandion Therapeutics (Acquired by Merck)Watertown, Massachusetts, USA2016
biotechautoimmune+2
Paratek PharmaceuticalsBoston, Massachusetts, USA1996
pharmaceuticalsantibiotics+2
PulmatrixLexington, Massachusetts, USA2003
biotechrespiratory+2
Seismic TherapeuticsCambridge, Massachusetts, USA2021
biotechimmunology+3
Dewpoint TherapeuticsBoston, Massachusetts, USA & Dresden, Germany2018
biotechbiomolecular-condensates+2